FDA Didn't Flub Approval In Orphan Drug Case, DC Court Says
By Lauren Berg · October 30, 2024, 11:48 PM EDT
The U.S. Food and Drug Administration didn't err in determining that a rival narcolepsy treatment is not the "same drug" as Jazz Pharmaceuticals' exclusive treatment, a D.C. federal judge ruled Wednesday,...
To view the full article, register now.